Preclinical efficacy testing of new drug candidates
EL Nuermberger - Tuberculosis and the Tubercle Bacillus, 2017 - Wiley Online Library
Since the early 1950s, combination chemotherapy has remained the strongest line of
defense against the ancient scourge of tuberculosis (TB). Between the years 2000 and 2015 …
defense against the ancient scourge of tuberculosis (TB). Between the years 2000 and 2015 …
Preclinical Efficacy Testing of New Drug Candidates.
EL Nuermberger - Microbiology Spectrum, 2017 - europepmc.org
This is a review of the preclinical efficacy testing of new antituberculosis drug candidates. It
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
Preclinical Efficacy Testing of New Drug Candidates
E Nuermberger - Microbiology spectrum, 2017 - jhu.pure.elsevier.com
This is a review of the preclinical efficacy testing of new antituberculosis drug candidates. It
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
Preclinical Efficacy Testing of New Drug Candidates
EL Nuermberger - Microbiology Spectrum, 2017 - Am Soc Microbiol
This is a review of the preclinical efficacy testing of new antituberculosis drug candidates. It
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
Preclinical Efficacy Testing of New Drug Candidates
EL Nuermberger - TUBERCLE BACILLUS, 2018 - Wiley Online Library
Successful treatment of active TB requires the use of drug combinations to efficiently
eradicate the diverse population of bacteria present in the infected host, including actively …
eradicate the diverse population of bacteria present in the infected host, including actively …
Preclinical Efficacy Testing of New Drug Candidates
EL Nuermberger - Microbiology spectrum, 2017 - pubmed.ncbi.nlm.nih.gov
This is a review of the preclinical efficacy testing of new antituberculosis drug candidates. It
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
Preclinical Efficacy Testing of New Drug Candidates
E Nuermberger - Microbiology spectrum, 2017 - pure.johnshopkins.edu
This is a review of the preclinical efficacy testing of new antituberculosis drug candidates. It
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and …
Preclinical efficacy testing of new drug candidates
EL Nuermberger - … and the Tubercle Bacillus: Second Edition, 2017 - pure.johnshopkins.edu
Since the early 1950s, combination chemotherapy has remained the strongest line of
defense against the ancient scourge of tuberculosis (TB). Between the years 2000 and 2015 …
defense against the ancient scourge of tuberculosis (TB). Between the years 2000 and 2015 …